Phase II Prospective Open Label Study of Pertuzumab, Trastuzumab, and Nab-Paclitaxel in Patients With HER-2 Positive Advanced Breast Cancer
Phase of Trial: Phase II
Latest Information Update: 26 Aug 2017
At a glance
- Drugs Paclitaxel (Primary) ; Pertuzumab (Primary) ; Trastuzumab (Primary)
- Indications Advanced breast cancer
- Focus Therapeutic Use
- 12 Jun 2017 Planned primary completion date changed from 1 Aug 2017 to 1 Aug 2018.
- 10 Jun 2017 Biomarkers information updated
- 30 Dec 2016 Planned primary completion date changed from 1 Jan 2017 to 1 Aug 2017.